Literature DB >> 12020524

Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study.

Matthijs Oudkerk1, Edwin J R van Beek, Piotr Wielopolski, Peter M A van Ooijen, Elise M J Brouwers-Kuyper, Alfons H H Bongaerts, Arie Berghout.   

Abstract

BACKGROUND: Diagnostic strategies for pulmonary embolism are complex and consist of non-invasive diagnostic tests done to avoid conventional pulmonary angiography as much as possible. We aimed to assess the diagnostic accuracy of magnetic resonance angiography (MRA) for the diagnosis of pulmonary embolism, using conventional pulmonary angiography as a reference method.
METHODS: In a prospective study, we enrolled 141 patients with suspected pulmonary embolism and an abnormal perfusion scan. Patients underwent MRA before conventional pulmonary angiography. Two reviewers, masked with respect to the results of conventional pulmonary angiography, assessed MRA images independently. Statistical analyses used chi(2) and 95% CI.
FINDINGS: MRA was contraindicated in 13 patients (9%), and images were not interpretable in eight (6%). MRA was done in two patients in whom conventional pulmonary angiography was contraindicated. Thus, MRA and conventional pulmonary angiography results were available in 118 patients (84%). Prevalence of pulmonary embolism was 30%. Images were read independently in 115 patients, and agreement obtained in 105 (91%), kappa=0.75. MRA identified 27 of 35 patients with proven pulmonary embolism (sensitivity 77%, 95% CI 61-90). Sensitivity of MRA for isolated subsegmental, segmental, and central or lobar pulmonary embolism was 40%, 84%, and 100%, respectively (p<0.01 for isolated subsegmental vs segmental or larger pulmonary embolism). However, subgroups contained small numbers. MRA identified pulmonary embolism in two patients with normal angiogram (98%, 92-100).
INTERPRETATION: MRA is sensitive and specific for segmental or larger pulmonary embolism. Results are similar to those obtained with helical computed tomography, but MRA has safer contrast agents and does not involve ionising radiation. MRA could become part of the diagnostic strategy for pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020524     DOI: 10.1016/S0140-6736(02)08596-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  53 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 2.  Assessment of pulmonary hypertension by CT and MR imaging.

Authors:  Sebastian Ley; Karl-Friedrich Kreitner; Christian Fink; Claus P Heussel; Mathias M Borst; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2004-01-23       Impact factor: 5.315

3.  3D pulmonary perfusion MRI and MR angiography of pulmonary embolism in pigs after a single injection of a blood pool MR contrast agent.

Authors:  Christian Fink; Sebastian Ley; Michael Puderbach; Christian Plathow; Michael Bock; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2004-03-03       Impact factor: 5.315

Review 4.  Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue.

Authors:  T Albrecht; A Oldenburg; J Hohmann; J Skrok; C W Hoffmann; S Schettler; K J Wolf
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 5.315

5.  Quantitative evaluation of MR perfusion imaging using blood pool contrast agent in subjects without pulmonary diseases and in patients with pulmonary embolism.

Authors:  Andreas Hansch; Peter Kohlmann; Uta Hinneburg; Joachim Boettcher; Ansgar Malich; Gunter Wolf; Hendrik Laue; Alexander Pfeil
Journal:  Eur Radiol       Date:  2012-04-01       Impact factor: 5.315

6.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

Review 7.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

8.  Three-dimensional T2-weighted imaging using the dark blood method for detecting pulmonary embolisms: comparison with computed tomography angiography.

Authors:  Mitsutomi Ishiyama; Masaki Matsusako; Katsunori Oikado; Yutaro Nishi; Kuniomi Ohi; Masaharu Hirano; Yukihisa Saida
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

Review 9.  Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT.

Authors:  John H Reid; Emmanuel E Coche; Tomio Inoue; Edmund E Kim; Maurizio Dondi; Naoyuki Watanabe; Giuliano Mariani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-27       Impact factor: 9.236

10.  Detection of acute pulmonary embolism: feasibility of diagnostic accuracy of MRI using a stepwise protocol.

Authors:  Waldemar Hosch; Martin Schlieter; Sebastian Ley; Tobias Heye; Hans-Ulrich Kauczor; Martin Libicher
Journal:  Emerg Radiol       Date:  2013-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.